In this way, they reactivated the expression of DNAM-1 in NK92 cells, after which NK92 DNAM-1+ cells were challenged against HeLa cervical cancer cells and had four times higher cytotoxicity than NK92 cells. This evidence concerns the gene CD226 and cervical cancer.